Global Inhalation Sevoflurane Anaesthetic Agent Market Research Report 2023
Sevoflurane, also called fluoromethyl, is an ether inhalation anaesthetic agent used for the induction and maintenance of general anesthesia.
According to QYResearch’s new survey, global Inhalation Sevoflurane Anaesthetic Agent market is projected to reach US$ 1443.4 million in 2029, increasing from US$ 976 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inhalation Sevoflurane Anaesthetic Agent market research.
The Inhalation Sevoflurane Anaesthetic Agent market is primarily driven by the demand for safe and effective inhalation anesthetic agents used during surgical procedures and medical interventions. Sevoflurane is a widely used inhalation anesthetic known for its rapid onset and recovery properties, making it suitable for both adults and pediatric patients. The increasing volume of surgical procedures, coupled with advancements in anesthesia technology and the focus on patient comfort, contributes to market growth. Moreover, the demonstrated benefits of sevoflurane in providing smooth induction and emergence from anesthesia, reducing side effects, and offering precise control over depth of anesthesia further propel adoption. However, challenges include optimizing dosing protocols, addressing potential adverse effects, and ensuring proper anesthetic management. Navigating patient-specific considerations, adhering to safety guidelines, and providing adequate training to anesthesiologists are ongoing concerns. The market's success relies on continuous research in anesthesia care, collaborations between pharmaceutical manufacturers and medical practitioners, and comprehensive education on the benefits and potential challenges of using sevoflurane as an inhalation anesthetic agent while addressing the evolving challenges associated with perioperative care and patient safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inhalation Sevoflurane Anaesthetic Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Inhalation Sevoflurane Anaesthetic Agent market is projected to reach US$ 1443.4 million in 2029, increasing from US$ 976 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inhalation Sevoflurane Anaesthetic Agent market research.
The Inhalation Sevoflurane Anaesthetic Agent market is primarily driven by the demand for safe and effective inhalation anesthetic agents used during surgical procedures and medical interventions. Sevoflurane is a widely used inhalation anesthetic known for its rapid onset and recovery properties, making it suitable for both adults and pediatric patients. The increasing volume of surgical procedures, coupled with advancements in anesthesia technology and the focus on patient comfort, contributes to market growth. Moreover, the demonstrated benefits of sevoflurane in providing smooth induction and emergence from anesthesia, reducing side effects, and offering precise control over depth of anesthesia further propel adoption. However, challenges include optimizing dosing protocols, addressing potential adverse effects, and ensuring proper anesthetic management. Navigating patient-specific considerations, adhering to safety guidelines, and providing adequate training to anesthesiologists are ongoing concerns. The market's success relies on continuous research in anesthesia care, collaborations between pharmaceutical manufacturers and medical practitioners, and comprehensive education on the benefits and potential challenges of using sevoflurane as an inhalation anesthetic agent while addressing the evolving challenges associated with perioperative care and patient safety.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inhalation Sevoflurane Anaesthetic Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AbbVie
- Baxter
- Maruishi Pharmaceutical
- Jiangsu Hengrui
- Lunan Pharmaceutical
- Generic Drug
- Brand Drug
- Chidren
- Adult
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET OVERVIEW
1.1 Product Overview and Scope of Inhalation Sevoflurane Anaesthetic Agent
1.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Type
1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2023-2029)
1.2.2 Generic Drug
1.2.3 Brand Drug
1.3 Inhalation Sevoflurane Anaesthetic Agent Segment by Application
1.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Value by Application: (2023-2029)
1.3.2 Chidren
1.3.3 Adult
1.4 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Estimates and Forecasts
1.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2029
1.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2029
1.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Manufacturers (2018-2023)
2.4 Global Inhalation Sevoflurane Anaesthetic Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Type & Application
2.7 Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation and Trends
2.7.1 Inhalation Sevoflurane Anaesthetic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue
2.7.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INHALATION SEVOFLURANE ANAESTHETIC AGENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2018-2029
3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2018-2023
3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2024-2029
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2018-2029
3.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2018-2023
3.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2024-2029
3.4 North America Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.4.1 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.4.3 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.5.1 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.5.3 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.7.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.7.3 Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2029)
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2024-2029)
4.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2029)
4.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2018-2029)
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2018-2023)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2024-2029)
4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2029)
4.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2029)
5.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023)
5.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2024-2029)
5.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2029)
5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2018-2029)
5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2018-2023)
5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2024-2029)
5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2018-2029)
5.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi Pharmaceutical
6.3.1 Maruishi Pharmaceutical Corporation Information
6.3.2 Maruishi Pharmaceutical Description and Business Overview
6.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.3.5 Maruishi Pharmaceutical Recent Developments/Updates
6.4 Jiangsu Hengrui
6.4.1 Jiangsu Hengrui Corporation Information
6.4.2 Jiangsu Hengrui Description and Business Overview
6.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.4.5 Jiangsu Hengrui Recent Developments/Updates
6.5 Lunan Pharmaceutical
6.5.1 Lunan Pharmaceutical Corporation Information
6.5.2 Lunan Pharmaceutical Description and Business Overview
6.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.5.5 Lunan Pharmaceutical Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Inhalation Sevoflurane Anaesthetic Agent Industry Chain Analysis
7.2 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process
7.4 Inhalation Sevoflurane Anaesthetic Agent Sales and Marketing
7.4.1 Inhalation Sevoflurane Anaesthetic Agent Sales Channels
7.4.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
7.5 Inhalation Sevoflurane Anaesthetic Agent Customers
8 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET DYNAMICS
8.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
8.2 Inhalation Sevoflurane Anaesthetic Agent Market Drivers
8.3 Inhalation Sevoflurane Anaesthetic Agent Market Challenges
8.4 Inhalation Sevoflurane Anaesthetic Agent Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Inhalation Sevoflurane Anaesthetic Agent
1.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Type
1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2023-2029)
1.2.2 Generic Drug
1.2.3 Brand Drug
1.3 Inhalation Sevoflurane Anaesthetic Agent Segment by Application
1.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Value by Application: (2023-2029)
1.3.2 Chidren
1.3.3 Adult
1.4 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Estimates and Forecasts
1.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2029
1.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2029
1.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Manufacturers (2018-2023)
2.4 Global Inhalation Sevoflurane Anaesthetic Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Type & Application
2.7 Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation and Trends
2.7.1 Inhalation Sevoflurane Anaesthetic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue
2.7.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INHALATION SEVOFLURANE ANAESTHETIC AGENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2018-2029
3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2018-2023
3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2024-2029
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2018-2029
3.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2018-2023
3.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2024-2029
3.4 North America Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.4.1 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.4.3 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.5.1 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.5.3 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.7.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.7.3 Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2029)
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2024-2029)
4.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2029)
4.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2018-2029)
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2018-2023)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2024-2029)
4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2029)
4.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2029)
5.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023)
5.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2024-2029)
5.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2029)
5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2018-2029)
5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2018-2023)
5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2024-2029)
5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2018-2029)
5.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi Pharmaceutical
6.3.1 Maruishi Pharmaceutical Corporation Information
6.3.2 Maruishi Pharmaceutical Description and Business Overview
6.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.3.5 Maruishi Pharmaceutical Recent Developments/Updates
6.4 Jiangsu Hengrui
6.4.1 Jiangsu Hengrui Corporation Information
6.4.2 Jiangsu Hengrui Description and Business Overview
6.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.4.5 Jiangsu Hengrui Recent Developments/Updates
6.5 Lunan Pharmaceutical
6.5.1 Lunan Pharmaceutical Corporation Information
6.5.2 Lunan Pharmaceutical Description and Business Overview
6.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
6.5.5 Lunan Pharmaceutical Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Inhalation Sevoflurane Anaesthetic Agent Industry Chain Analysis
7.2 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process
7.4 Inhalation Sevoflurane Anaesthetic Agent Sales and Marketing
7.4.1 Inhalation Sevoflurane Anaesthetic Agent Sales Channels
7.4.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
7.5 Inhalation Sevoflurane Anaesthetic Agent Customers
8 INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET DYNAMICS
8.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
8.2 Inhalation Sevoflurane Anaesthetic Agent Market Drivers
8.3 Inhalation Sevoflurane Anaesthetic Agent Market Challenges
8.4 Inhalation Sevoflurane Anaesthetic Agent Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inhalation Sevoflurane Anaesthetic Agent, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Type & Application
Table 12. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023) & (K Units)
Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2018-2023)
Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2024-2029) & (K Units)
Table 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2024-2029)
Table 21. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2018-2023)
Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2024-2029)
Table 25. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 27. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 28. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 32. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 33. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Type (2018-2023)
Table 51. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Type (2024-2029)
Table 52. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Table 53. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2024-2029)
Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2023)
Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2024-2029)
Table 58. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2018-2023)
Table 59. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2024-2029)
Table 60. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Application (2018-2023)
Table 61. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Application (2024-2029)
Table 62. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Table 63. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2024-2029)
Table 64. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2018-2023)
Table 67. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2024-2029)
Table 68. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2018-2023)
Table 69. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2024-2029)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Baxter Inhalation Sevoflurane Anaesthetic Agent Product
Table 79. Baxter Recent Developments/Updates
Table 80. Maruishi Pharmaceutical Corporation Information
Table 81. Maruishi Pharmaceutical Description and Business Overview
Table 82. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product
Table 84. Maruishi Pharmaceutical Recent Developments/Updates
Table 85. Jiangsu Hengrui Corporation Information
Table 86. Jiangsu Hengrui Description and Business Overview
Table 87. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product
Table 89. Jiangsu Hengrui Recent Developments/Updates
Table 90. Lunan Pharmaceutical Corporation Information
Table 91. Lunan Pharmaceutical Description and Business Overview
Table 92. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product
Table 94. Lunan Pharmaceutical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Inhalation Sevoflurane Anaesthetic Agent Distributors List
Table 98. Inhalation Sevoflurane Anaesthetic Agent Customers List
Table 99. Inhalation Sevoflurane Anaesthetic Agent Market Trends
Table 100. Inhalation Sevoflurane Anaesthetic Agent Market Drivers
Table 101. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
Table 102. Inhalation Sevoflurane Anaesthetic Agent Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inhalation Sevoflurane Anaesthetic Agent, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Product Type & Application
Table 12. Global Key Manufacturers of Inhalation Sevoflurane Anaesthetic Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023) & (K Units)
Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2018-2023)
Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2024-2029) & (K Units)
Table 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2024-2029)
Table 21. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2018-2023)
Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2024-2029)
Table 25. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 27. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 28. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 32. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 33. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Type (2018-2023)
Table 51. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Type (2024-2029)
Table 52. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Table 53. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2024-2029)
Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2023)
Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2024-2029)
Table 58. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2018-2023)
Table 59. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2024-2029)
Table 60. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Application (2018-2023)
Table 61. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units) by Application (2024-2029)
Table 62. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Table 63. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2024-2029)
Table 64. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2018-2023)
Table 67. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2024-2029)
Table 68. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2018-2023)
Table 69. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2024-2029)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Baxter Inhalation Sevoflurane Anaesthetic Agent Product
Table 79. Baxter Recent Developments/Updates
Table 80. Maruishi Pharmaceutical Corporation Information
Table 81. Maruishi Pharmaceutical Description and Business Overview
Table 82. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product
Table 84. Maruishi Pharmaceutical Recent Developments/Updates
Table 85. Jiangsu Hengrui Corporation Information
Table 86. Jiangsu Hengrui Description and Business Overview
Table 87. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product
Table 89. Jiangsu Hengrui Recent Developments/Updates
Table 90. Lunan Pharmaceutical Corporation Information
Table 91. Lunan Pharmaceutical Description and Business Overview
Table 92. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product
Table 94. Lunan Pharmaceutical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Inhalation Sevoflurane Anaesthetic Agent Distributors List
Table 98. Inhalation Sevoflurane Anaesthetic Agent Customers List
Table 99. Inhalation Sevoflurane Anaesthetic Agent Market Trends
Table 100. Inhalation Sevoflurane Anaesthetic Agent Market Drivers
Table 101. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
Table 102. Inhalation Sevoflurane Anaesthetic Agent Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Inhalation Sevoflurane Anaesthetic Agent
Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type in 2022 & 2029
Figure 4. Generic Drug Product Picture
Figure 5. Brand Drug Product Picture
Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application in 2022 & 2029
Figure 8. Chidren
Figure 9. Adult
Figure 10. Global Inhalation Sevoflurane Anaesthetic Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (2018-2029) & (US$ Million)
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2018-2029) & (K Units)
Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) & (2018-2029)
Figure 14. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers in 2022
Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players: Market Share by Revenue in 2022
Figure 18. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 21. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 22. United States Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 25. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 26. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2018-2029)
Figure 33. China Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 43. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2018-2029)
Figure 53. Global Revenue Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2018-2029)
Figure 54. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Application (2018-2029)
Figure 56. Global Revenue Market Share of Inhalation Sevoflurane Anaesthetic Agent by Application (2018-2029)
Figure 57. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2018-2029)
Figure 58. Inhalation Sevoflurane Anaesthetic Agent Value Chain
Figure 59. Inhalation Sevoflurane Anaesthetic Agent Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Inhalation Sevoflurane Anaesthetic Agent
Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type in 2022 & 2029
Figure 4. Generic Drug Product Picture
Figure 5. Brand Drug Product Picture
Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application in 2022 & 2029
Figure 8. Chidren
Figure 9. Adult
Figure 10. Global Inhalation Sevoflurane Anaesthetic Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (2018-2029) & (US$ Million)
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2018-2029) & (K Units)
Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) & (2018-2029)
Figure 14. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers in 2022
Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Inhalation Sevoflurane Anaesthetic Agent Players: Market Share by Revenue in 2022
Figure 18. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 21. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 22. United States Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 25. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 26. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2018-2029)
Figure 33. China Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 43. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2018-2029)
Figure 53. Global Revenue Market Share of Inhalation Sevoflurane Anaesthetic Agent by Type (2018-2029)
Figure 54. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Inhalation Sevoflurane Anaesthetic Agent by Application (2018-2029)
Figure 56. Global Revenue Market Share of Inhalation Sevoflurane Anaesthetic Agent by Application (2018-2029)
Figure 57. Global Inhalation Sevoflurane Anaesthetic Agent Price (US$/Unit) by Application (2018-2029)
Figure 58. Inhalation Sevoflurane Anaesthetic Agent Value Chain
Figure 59. Inhalation Sevoflurane Anaesthetic Agent Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
